- Overview
- Immunogenicity
- About
- Protected: Assays
- Reid Bioanalytical Forum 2022
- Outsourcing in Clinical Trials East Coast 2022
- Celerion Sell Page 2022
- 6th Obesity & NASH Drug Development Summit
- Poster Presentation
- 15th EBF Open Symposium
- Thank You 2022
- EBF Conference 2021
- DIA 2022
- Copy of Brand Afffffwareness – Linkedin
- Rifampin Alternatives for DDI Studies in Response to Nitrosamine Impurities
- Outsourcing in Clinical Trials Southern California
- Outsourcing In Clinical Trials Europe 2023
- Outsourcing In Clinical Trials & Clinical Trial Supply Israel 2023
- Outsourcing in Clinical Trials East Coast 2023
- SCOPE – Summit For Clinical Ops Executives 2023
- DIA 2023
- ASCPT 2023 Annual Meeting
- WRIB 2023
- RSVP
- Outsourcing in Clinical Trials West Coast 2023
- Outsourcing in Clinical Trials Southern California 2023
- Outsourcing in Clinical Trials New England 2023
- 16th EBF Open Symposium 2023
- Brand Awareness – Linkedin
- 16th WRIB Conference
- Outsourcing in Clinical Trials West Coast 2022
- Product Labeling Studies – Linkedin
- Outsourcing in Clinical Trials New England 2022
- Outsourcing in Clinical Trials Southern California 2022
- Oxford Global: Biomarkers UK Conference 2021
- Celerion Sell Page 2022 Number 2
- Bioanalytical Sciences
- Biomarkers
- Biosimilars
- Careers
- Protected: Celerion Jobs Tempe
- Chromatography
- Contact
- Covid-19
- COVID-19 Blog
- COVID-19 regulatory guidance
- COVID-19 Resources
- EBF quiz
- EBF Thank You
- Equipment List
- Experience
- Expertise
- Gene Therapy
- Home
- Innovations
- Inside the Pharmacy
- Investigators
- Ligand-Binding
- Metabolite Profiling
- Our Scientists
- Peptides/Oligos
- Participate in a Study
- PK/PD
- Pharmacy
- Privacy Policy
- Protected: Quality & Speed
- Request For Proposal
- Resources
- Services
- Test
Key Strategies for Small Molecule Bioanalysis
However complex your bioanalytical challenge, we will help you achieve an excellent study outcome. We have the most comprehensive list of assays in the industry, with over 500 off the shelf assays to support small molecule bioanalysis.
Our experience and expertise in traditional small molecule, metabolite, including peptide and oligonucleotide bioanalysis. Plus, we have the capacity to meet your study timelines. Our established laboratories are located in Lincoln, Nebraska and Zurich, Switzerland.
Celerion’s highly-qualified scientists have on average more than 10 years of industry experience developing bioanalytical methods to support small molecule bioanalysis. We provide full GLP-compliant services in method validation and sample analysis for traditional small molecules, metabolites, therapeutic proteins, biomarkers, antibodies, nucleic acids, and peptides. The team offers expertise in the LC-MS/MS analysis of endogenous biomarkers, their congeners and metabolites such as leukotrienes, prostaglandins, peptides, steroids and other compounds.
Our method development capabilities include sensitive and reliable bioanalytical methods for generics and New Molecular Entities (NME). We have overcome challenging methods, such as those requiring drug derivatization, chiral separation, drug stabilization, and multiple metabolite quantitation.
We use the most advanced technologies and strategies to ensure on-time delivery of high-quality data. Small molecule work is performed using LC-MS/MS with HPLC, UPLC, 2D-chromatography or MicroLC techniques. We also utilize state-of-the-art automation technologies such as Caliper Sciclone, Hamilton, Tecan to automate sample analysis processes and deliver data to you quickly and efficiently. With over 42 LC-MS/MS instruments available for method development, validation and sample analysis, Celerion has the capacity and expertise to meet and exceed your study timelines.
Application of 2D-Chromatography
The Development of a method for the Determination of Cortisol and 6-Beta-Hydroxycortisol in Human Urine Using 2D-Chromatography
Seeing through the MIST: Metabolite Identification and Profiling Strategies
While an understanding a drug’s metabolism has been a critical element of drug development for fifty years, evolving medical science and technology has added increasing sophistication to how this work is done today.
Contact
Translating Your Science to Medicine.
Partner with us to get fast, actionable data you can rely on.